✦ LIBER ✦

Vascular Access Site Complications After Percutaneous Coronary Intervention With Abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Trial

✍ Scribed by James C. Blankenship MD; Anne S. Hellkamp MS; Frank V. Aguirre MD; S.Lee Demko RN; Eric J. Topol MD; Robert M. Califf MD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of bolus-only platelet glycoprot

✍ Jonathan D. Marmur; Cristina A. Mitre; Elliot Barnathan; Erdal Cavusoglu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Bivalirudin with planned or provisional

✍ A.Michael Lincoff; Neal S. Kleiman; Kandace Kottke-Marchant; Elizabeth S. Maiers 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Modifiable Risk Factors for Vascular Acc

✍ Jeffrey S. Mandak; James C. Blankenship; Laura H. Gardner; Scott D. Berkowitz; F 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Impact of anemia in patients with acute

✍ E. Nikolsky; E.D. Aymong; A. Halkin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Impact of anemia in patients with acute

✍ Eugenia Nikolsky; Eve D. Aymong; Amir Halkin; Cindy L. Grines; David A. Cox; Eul 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Multicenter Randomized Trial Evaluating

✍ Jung-Won Suh; Seung-Pyo Lee; Kyung-Woo Park; Hae-Young Lee; Hyun-Jae Kang; Bon-K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 959 KB